Hippocrates VC
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
Industries
- Health Tech
- Biotechnology
- AI
- Data Science
About
Hippocrates VC is at the forefront of innovation in healthcare, specializing in the development of evidence-based digital therapeutics that leverage virtual reality neuromodulation. By integrating advanced technology with clinical insights, Hippocrates enhances patient experiences and outcomes across a diverse range of medical procedures. The company is dedicated to empowering individuals with life-saving tools, fostering greater self-management of health conditions and improving overall wellness. Through a commitment to scientific rigor and user-centered design, Hippocrates VC is transforming the way patients engage with their healthcare journeys.
Hippocrates VC is at the forefront of innovation in healthcare, specializing in the development of evidence-based digital therapeutics that leverage virtual reality neuromodulation. By integrating advanced technology with clinical insights, Hippocrates enhances patient experiences and outcomes across a diverse range of medical procedures. The company is dedicated to empowering individuals with life-saving tools, fostering greater self-management of health conditions and improving overall wellness. Through a commitment to scientific rigor and user-centered design, Hippocrates VC is transforming the way patients engage with their healthcare journeys.
Investment Thesis
Hippocrates VC is the worlds first physicianfunded social impact digital therapeutics venture capital fund. They invest in early stage digital therapeutics and healthcare startups that have the potential to create a significant social impact.
Manager's Experience
Backed by over a decade of investment experience, the fund manager has built a diverse portfolio primarily focusing on technology and healthcare sectors in North America and Europe. With a strong emphasis on early to growth-stage investments, they have successfully executed more than 30 deals, demonstrating a data-driven and thematic approach to capital allocation. Notable exits include several high-profile companies that have achieved significant market valuations, reflecting the manager's strategic foresight and operational insights. Their expertise in navigating complex market dynamics is complemented by a commitment to fostering innovation within their investment thesis.